Last reviewed · How we verify

NCT00398034

Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-treated Chronic Pain Patients: A Pilot Study.

Withdrawn Phase 2 Last updated 13 October 2023
What this trial tests

Phase 2 trial testing Testosterone Gel in Pain. Withdrawn.

Timeline
30 October 2006
Primary endpoint
6 September 2007
6 September 2007

Quick facts

Lead sponsorJames J. Peters Veterans Affairs Medical Center
PhasePhase 2
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Start date30 October 2006
Primary completion6 September 2007
Estimated completion6 September 2007

Drugs / interventions tested

Conditions studied

Sponsor

James J. Peters Veterans Affairs Medical Center

Who can join

Adults 18 to 60, male only, with Pain or Hypogonadism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this pilot study is to test the effects of testosterone replacement on pain, fatigue, mood, cognition and libido in hypogonadal men on long-term opioid therapy for chronic pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Testosterone Gel

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other James J. Peters Veterans Affairs Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00398034.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing